Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-23-000122

EVP, Chief Financial Officer acquired 73,847 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
LINDAHL RICHARD S EVP, Chief Financial Officer 2023-06-09 Grant or award +24,616 123,761 D
LINDAHL RICHARD S EVP, Chief Financial Officer 2023-06-09 Grant or award +49,231 172,992 D
Derivatives
LINDAHL RICHARD S EVP, Chief Financial Officer 2023-06-09 Grant or award · Employee Stock Option (Right to buy) +49,231 180,944 D
Loading xslF345X04/wk-form4_1686705705.xml…